SAB Biotherapeutics, Inc. — SC 13G Filings
5 SC 13G filings on record
This page lists all SC 13G filings submitted to the SEC by SAB Biotherapeutics, Inc. (SABSW), sorted by most recent first. Each row links to the full filing on EdgarLookup. SAB Biotherapeutics, Inc. has filed 5 SC 13G documents with the SEC since 2020. To view all SEC filings by SAB Biotherapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
25-NSE
3
4
4/A
424B3
424B4
424B5
425
5
8-A12B
8-K
8-K/A
AW
CERT
CORRESP
D
DEF 14A
DEFA14A
DRSLTR
EFFECT
NT 10-K
NT 10-Q
POS AM
PRE 14A
RW
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G | SAB BIOTHERAPEUTICS, INC. | 0000902664-24-001535 | Feb 14, 2024 | — |
| SC 13G | SCHEDULE 13G | 0000921895-23-002708 | Dec 4, 2023 | — |
| SC 13G | — | 0001493152-23-037345 | Oct 16, 2023 | — |
| SC 13G | BIG CYPRESS ACQUISITION CORP. | 0001104659-21-127418 | Oct 19, 2021 | — |
| SC 13G | SC 13G | 0001140361-21-005965 | Feb 24, 2021 | — |